The "occlusis" model of cell fate restriction

BioEssays

Volumn 33, Issue 1, 2011, Pages 13-20

  Lahn, Bruce T ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cell fate restriction; Deocclusion; Occludome; Occlusion; Occlusis

Indexed keywords

TRANS ACTING FACTOR;

ARTICLE; CELL FATE; CELL LINEAGE; CHROMATIN; GENETIC TRANSCRIPTION; GENOME; MODEL; PHYSICAL DEVELOPMENT; PLURIPOTENT STEM CELL; REPRODUCTION; ZYGOTE;

ANIMALS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CHROMATIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; GENOME; HUMANS; MODELS, BIOLOGICAL; PLURIPOTENT STEM CELLS; REPRODUCTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 78650010371     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201000090     Document Type: Article

References (79)

1. Blau HM, Baltimore D. 1991. Differentiation requires continuous regulation. J Cell Biol 112: 781-3.
2. Graf T, Enver T. 2009. Forcing cells to change lineages. Nature 462: 587-94.
3. Yamanaka S, Blau HM. 2010. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465: 704-12.
4. Reik W. 2007. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447: 425-32.
5. Goldberg AD, Allis CD, Bernstein E. 2007. Epigenetics: a landscape takes shape. Cell 128: 635-8.
6. Lee JH, Bugarija B, Millan EJ, Walton NM, et al. 2009. Systematic identification of cis-silenced genes by trans complementation. Hum Mol Genet 18: 835-46.
7. Waddington CH. 1940. Organisers and Genes. London: Cambridge University Press.
8. Waddington CH. 1957. The Strategy of the Genes. London: George Allen & Unwin.
9. Caplan AI, Ordahl CP. 1978. Irreversible gene repression model for control of development. Science 201: 120-30.
10. Bartolomei MS, Tilghman SM. 1997. Genomic imprinting in mammals. Annu Rev Genet 31: 493-525.
11. Goldmit M, Bergman Y. 2004. Monoallelic gene expression: a repertoire of recurrent themes. Immunol Rev 200: 197-214.
12. Valley CM, Willard HF. 2006. Genomic and epigenomic approaches to the study of X chromosome inactivation. Curr Opin Genet Dev 16: 240-5.
13. Boshart M, Nitsch D, Schutz G. 1993. Extinction of gene expression in somatic cell hybrids-a reflection of important regulatory mechanisms? Trends Genet 9: 240-5.
14. Schneider JA, Weiss MC. 1971. Expression of differentiated functions in hepatoma cell hybrids. I. Tyrosine aminotransferase in hepatoma-fibroblast hybrids. Proc Natl Acad Sci USA 68: 127-31.
15. Weiss MC, Chaplain M. 1971. Expression of differentiated functions in hepatoma cell hybrids: reappearance of tyrosine aminotransferase inducibility after the loss of chromosomes. Proc Natl Acad Sci USA 68: 3026-30.
16. Davidson RL. 1974. Gene expression in somatic cell hybrids. Annu Rev Genet 8: 195-218.
17. Blau HM, Chiu CP, Webster C. 1983. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32: 1171-80.
18. Chiu CP, Blau HM. 1984. Reprogramming cell differentiation in the absence of DNA synthesis. Cell 37: 879-87.
19. Wright WE. 1984. Expression of differentiated functions in heterokaryons between skeletal myocytes, adrenal cells, fibroblasts and glial cells. Exp Cell Res 151: 55-69.
20. Wright WE. 1984. Induction of muscle genes in neural cells. J Cell Biol 98: 427-35.
21. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, et al. 1985. Plasticity of the differentiated state. Science 230: 758-66.
22. Baron MH, Maniatis T. 1986. Rapid reprogramming of globin gene expression in transient heterokaryons. Cell 46: 591-602.
23. Blau HM. 1989. How fixed is the differentiated state? Lessons from heterokaryons. Trends Genet 5: 268-72.
24. Spear BT, Tilghman SM. 1990. Role of alpha-fetoprotein regulatory elements in transcriptional activation in transient heterokaryons. Mol Cell Biol 10: 5047-54.
25. Nitsch D, Boshart M, Schutz G. 1993. Extinction of tyrosine aminotransferase gene activity in somatic cell hybrids involves modification and loss of several essential transcriptional activators. Genes Dev 7: 308-19.
26. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293: 1074-80.
27. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 (Suppl): 245-54.
28. Vermaak D, Ahmad K, Henikoff S. 2003. Maintenance of chromatin states: an open-and-shut case. Curr Opin Cell Biol 15: 266-74.
29. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
30. Li B, Carey M, Workman JL. 2007. The role of chromatin during transcription. Cell 128: 707-19.
31. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, et al. 2007. Genome regulation by polycomb and trithorax proteins. Cell 128: 735-45.
32. Surani MA, Hayashi K, Hajkova P. 2007. Genetic and epigenetic regulators of pluripotency. Cell 128: 747-62.
33. Baylin S, Bestor TH. 2002. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1: 299-305.
34. Ptashne M. 2007. On the use of the word 'epigenetic'. Curr Biol 17: R233-6.
35. Gurdon JB. 1962. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 10: 622-40.
36. Wilmut I, Schnieke AE, McWhir J, Kind AJ, et al. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810-3.
37. Hochedlinger K, Jaenisch R. 2006. Nuclear reprogramming and pluripotency. Nature 441: 1061-7.
38. Tada M, Tada T, Lefebvre L, Barton SC, et al. 1997. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. Embo J 16: 6510-20.
39. Tada M, Takahama Y, Abe K, Nakatsuji N, et al. 2001. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11: 1553-8.
40. Do JT, Scholer HR. 2004. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22: 941-9.
41. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-76.
42. Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-7.
43. Maherali N, Sridharan R, Xie W, Utikal J, et al. 2007. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70.
44. Wernig M, Meissner A, Foreman R, Brambrink T, et al. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-24.
45. Jackson KA, Mi T, Goodell MA. 1999. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 96: 14482-6.
46. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390-4.
47. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, et al. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528-30.
48. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, et al. 1999. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283: 534-7.
49. Brazelton TR, Rossi FM, Keshet GI, Blau HM. 2000. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290: 1775-9.
50. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, et al. 2000. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6: 1229-34.
51. Mezey E, Chandross KJ, Harta G, Maki RA, et al. 2000. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290: 1779-82.
52. Clarke DL, Johansson CB, Wilbertz J, Veress B, et al. 2000. Generalized potential of adult neural stem cells. Science 288: 1660-3.
53. Galli R, Borello U, Gritti A, Minasi MG, et al. 2000. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 3: 986-91.
54. Priller J, Persons DA, Klett FF, Kempermann G, et al. 2001. Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo. J Cell Biol 155: 733-8.
55. Krause DS, Theise ND, Collector MI, Henegariu O, et al. 2001. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-77.
56. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-5.
57. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-9.
58. Slack JM. 2007. Metaplasia and transdifferentiation: from pure biology to the clinic. Nat Rev Mol Cell Biol 8: 369-78.
59. Terada N, Hamazaki T, Oka M, Hoki M, et al. 2002. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416: 542-5.
60. Ying QL, Nichols J, Evans EP, Smith AG. 2002. Changing potency by spontaneous fusion. Nature 416: 545-8.
61. McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, et al. 2002. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 99: 1341-6.
62. Wells WA. 2002. Is transdifferentiation in trouble? J Cell Biol 157: 15-8.
63. Rodic N, Rutenberg MS, Terada N. 2004. Cell fusion and reprogramming: resolving our transdifferences. Trends Mol Med 10: 93-6.
64. Carrel L, Willard HF. 2005. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434: 400-4.
65. Sanchez Alvarado A, Tsonis PA. 2006. Bridging the regeneration gap: genetic insights from diverse animal models. Nat Rev Genet 7: 873-84.
66. Esteller M. 2008. Epigenetics in cancer. N Engl J Med 358: 1148-59.
67. Sharma S, Kelly TK, Jones PA. 2009. Epigenetics in cancer. Carcinogenesis.
68. Calvanese V, Lara E, Kahn A, Fraga MF. 2009. The role of epigenetics in aging and age-related diseases. Ageing Res Rev 8: 268-76.
69. Payer B, Lee JT. 2008. X chromosome dosage compensation: how mammals keep the balance. Annu Rev Genet 42: 733-72.
70. Eggan K, Akutsu H, Hochedlinger K, Rideout W 3rd, et al. 2000. X-Chromosome inactivation in cloned mouse embryos. Science 290: 1578-81.
71. Inoue K, Kohda T, Lee J, Ogonuki N, et al. 2002. Faithful expression of imprinted genes in cloned mice. Science 295: 297.
72. Brown CJ, Lafreniere RG, Powers VE, Sebastio G, et al. 1991. Localization of the X inactivation centre on the human X chromosome in Xq13. Nature 349: 82-4.
73. Brown CJ, Willard HF. 1994. The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature 368: 154-6.
74. Rack KA, Chelly J, Gibbons RJ, Rider S, et al. 1994. Absence of the XIST gene from late-replicating isodicentric X chromosomes in leukaemia. Hum Mol Genet 3: 1053-9.
75. Csankovszki G, Panning B, Bates B, Pehrson JR, et al. 1999. Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation. Nat Genet 22: 323-4.
76. Rajan P, Snyder E. 2006. Neural stem cells and their manipulation. Methods Enzymol 419: 23-52.
77. Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, et al. 2007. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448: 191-5.
78. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, et al. 2007. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448: 196-9.
79. Guo G, Yang J, Nichols J, Hall JS, et al. 2009. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136: 1063-9.